Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 Earnings

Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 Earnings

NeoGenomics Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows

NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates

NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates

NeoGenomics Reports First Quarter 2024 Results

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

NeoGenomics Announces Senior Leadership Promotions

Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?

Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy

All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy

Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect?

Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect?

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report